During the past decade, Jinnouchi Neurosurgical Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Jinnouchi Neurosurgical Clinic" are "Migraine" (2 trials). Many other conditions were trialed in "Jinnouchi Neurosurgical Clinic" in a lesser frequency.

Most popular intervention types in "Jinnouchi Neurosurgical Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Rimegepant" (1 trials), "Rimegepant 25 MG" (1 trials) and "Rimegepant 75 MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jinnouchi Neurosurgical Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Jinnouchi Neurosurgical Clinic". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Jinnouchi Neurosurgical Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jinnouchi Neurosurgical Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".